Biomunex CEO On Earlier Deals For Cancer Drugs
Biomunex CEO Pierre Emmanuel Gerard discusses the company's founding, its pipeline of innovative bispecific antibodies being developed for oncological indications, and the partnering potential for these compounds.
You may also be interested in...
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
The stereotypical view of an Alzheimer’s patient as an elderly person needs to change and interventions made earlier in the disease course, while we wait for novel drug therapies, said experts at a recent virtual meeting.
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the novel coronavirus pandemic. While Biopharma companies secured more than $7.5bn in private financings between January and June.